(Q33560112)

28 July 2017

1 reference

title

Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis (English)

1 reference

28 July 2017

1 reference

Barradell LB

1

1 reference

28 July 2017

McTavish D

series ordinal

2

1 reference

28 July 2017

publication date

1 June 1993

1 reference

28 July 2017

1 reference

28 July 2017

volume

3

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

482-510

1 reference

Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients

28 July 2017

cites work

1 reference

12 December 2020

Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research

1 reference

12 December 2020

Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients

1 reference

12 December 2020

Peptic ulcer pathophysiology

1 reference

12 December 2020

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

1 reference

12 December 2020

Omeprazole versus ranitidine in the treatment of resistant duodenal ulcer

1 reference

12 December 2020

Double-blind comparison of omeprazole 20 mg OM and ranitidine 300 mg NOCTE in duodenal ulcer: a Taiwan multi-centre study

1 reference

12 December 2020

Epidemiology of duodenal erosions.

1 reference

12 December 2020

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations

1 reference

12 December 2020

Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.

1 reference

12 December 2020

Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

1 reference

12 December 2020

Function and structure of parietal cells after H+-K+-ATPase blockade

1 reference

12 December 2020

Three year follow up of patients with gastrooesophageal reflux disease

1 reference

12 December 2020

Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis

1 reference

12 December 2020

Prevalence of symptoms of dyspepsia in the community

1 reference

12 December 2020

Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials

1 reference

12 December 2020

24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients

1 reference

12 December 2020

Provision of gastrointestinal endoscopy and related services for a district general hospital. Working Party of the Clinical Services Committee of the British Society of Gastroenterology

1 reference

12 December 2020

Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders

1 reference

12 December 2020

Cost-effectiveness analysis of medical and surgical treatment for duodenal ulcer in Singapore

1 reference

12 December 2020

Cost-effectiveness of alternative medications in the treatment of duodenal ulcer

1 reference

12 December 2020

Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment

1 reference

12 December 2020

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

12 December 2020

Tropical peptic ulcer disease: an endoscopic study from rural Haiti

1 reference

12 December 2020

A comparison of omeprazole and ranitidine for duodenal ulcer in South African patients. A multiracial study

1 reference

12 December 2020

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

1 reference

12 December 2020

Natural history of gastro-oesophageal reflux disease without oesophagitis

1 reference

12 December 2020

Costs of medical and surgical treatment of duodenal ulcer.

1 reference

12 December 2020

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

12 December 2020

The pathophysiology of peptic ulcer disease

1 reference

12 December 2020

The clinical safety of omeprazole

1 reference

12 December 2020

Costs and benefits in the treatment of duodenal ulcers

1 reference

12 December 2020

Clinical aspects of gastroduodenal ulcer recurrence: an overview

1 reference

12 December 2020

Intermittent treatment of duodenal ulcer for long term medical management.

1 reference

12 December 2020

Pathogenesis and management of gastroesophageal reflux disease.

1 reference

12 December 2020

Economic and health aspects of peptic ulcer disease and H2-receptor antagonists

1 reference

12 December 2020

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

1 reference

12 December 2020

Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine.

1 reference

12 December 2020

Testing the efficacy of antisecretory drugs in patients with haematemesis and melaena

1 reference

12 December 2020

Medical Treatment of Peptic Ulcer Disease

1 reference

12 December 2020

Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders

1 reference

12 December 2020

Epidemiology in peptic ulcer disease. Current status and future aspects

1 reference

12 December 2020

Comparative tolerability profile of omeprazole in clinical trials

1 reference

12 December 2020

The relationship between gastric acid secretion and gastric H+,K+-ATPase activity

1 reference

12 December 2020

Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.

1 reference

12 December 2020

1 reference

12 December 2020

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

1 reference

12 December 2020

Comparative efficacy of omeprazole and cimetidine in the treatment of duodenal ulcer in the acute stage. A French multicenter, controlled therapeutic trial

1 reference

12 December 2020

Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: a multicenter double-blind, parallel group study

1 reference

12 December 2020

Lack of eradication of Helicobacter pylori after omeprazole

1 reference

12 December 2020

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring

1 reference

12 December 2020

[Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium]

1 reference

12 December 2020

Principles of pharmacoeconomic analysis of drug therapy

1 reference

12 December 2020

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

1 reference

12 December 2020

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

1 reference

12 December 2020

Omeprazole 20 mg daily for duodenal ulcer: a multicentre study

1 reference

12 December 2020

Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa

1 reference

12 December 2020

Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine

1 reference

12 December 2020

Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pylori

1 reference

12 December 2020

Age of onset of symptoms in duodenal and gastric ulcer

1 reference

12 December 2020

Duodenal ulcer disease: to treat H. pylori infection or not?

1 reference

12 December 2020

Effect of omeprazole on H. pylori after two weeks of treatment

1 reference

12 December 2020

Cost and Quality Effects of Alternative Treatments for Persistent Gastroesophageal Reflux Disease

1 reference

12 December 2020

Changing Pattern of Peptic Ulcer in India. An Endoscopic Study of 1,188 Ulcer Patients

1 reference

12 December 2020

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis.

1 reference

12 December 2020

Drugs for treatment of peptic ulcers

1 reference

12 December 2020

Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial

1 reference

12 December 2020

Specific labelling of gastric H+,K+-ATPase by omeprazole

1 reference

12 December 2020

Safety experience from long-term treatment with omeprazole

1 reference

12 December 2020

Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study

1 reference

12 December 2020

1 reference

12 December 2020

Symptom relief and duodenal ulcer healing with omeprazole or cimetidine. Opus (Omeprazole Peptic Ulcer Study) Research Group

1 reference

12 December 2020

Epidemiology of oesophageal reflux disease

1 reference

12 December 2020

[Omeprazole is more cost-effective than ranitidine in reflux esophagitis]

1 reference

12 December 2020

Omeprazole in H2 receptor antagonist-resistant reflux esophagitis

1 reference

12 December 2020

The Kaplan and Meier and the Nelson Estimate for the Probability of Ulcer Recurrence 10 and 15 Years after Parietal Cell Vagotomy

1 reference

12 December 2020

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

1 reference

12 December 2020

Treatment of peptic ulcer in general practice and in hospital: a comparison of omeprazole and cimetidine

1 reference

12 December 2020

Study designs and diagnostic criteria need standardization to effectively compare worldwide ulcer trends

1 reference

12 December 2020

Australian clinical trials of omeprazole in the management of reflux oesophagitis

1 reference

12 December 2020

H2 antagonist and omeprazole nonresponders

1 reference

12 December 2020

Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers

1 reference

12 December 2020

10.2165/00019053-199303060-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1015558500

0 references

1 reference